Ultima-Nolva by Ultima Pharmaceuticals

Brand: Ultima Pharmaceuticals

Substance: Tamoxifen Citrate

Action of the Drug

Ultima-Nolva provides tamoxifen citrate, a selective estrogen receptor modulator (SERM) designed for research on estrogenic activity modulation and post-cycle therapy protocols.

Use in Sports

Used in studies to evaluate recovery of natural testosterone production, estrogen receptor interaction, and prevention of estrogen-related effects during and after anabolic research cycles.

Period of Drug Withdrawal

Effects taper within 1–2 weeks after cessation, allowing precise observation of hormonal responses in research.

Rate of Suppression of Natural Testosterone Production

Tamoxifen citrate does not suppress endogenous testosterone and can support recovery in studies involving prior anabolic compounds.

What Should Be Used During and After Use

During use:

• Follow study-specific dosing schedules
• Monitor hormonal and physiological parameters

After use:

• Post-study evaluation of hormonal recovery

Combinations with Other Anabolic and Androgenic Drugs

Ultima-Nolva can be included in research with anabolic compounds to analyze anti-estrogenic effects and recovery efficiency during post-cycle therapy studies.

Possible Side Effects and How to Avoid Them

• Minor gastrointestinal discomfort – study-specific dosing recommended
• Hormonal fluctuations – monitoring advised

Why We Recommend It

Ultima-Nolva provides a reliable option for estrogen modulation research and post-cycle therapy studies with tamoxifen citrate.

Comparison with Other Drugs

Compared to other SERMs, tamoxifen citrate offers well-documented activity for hormonal research and recovery evaluation.

Main Properties

• Estrogen Modulation: Selectively interacts with estrogen receptors
• PCT Support: Aids research on post-cycle recovery
• Hormonal Balance: Supports studies on testosterone restoration
• Well-Researched Compound: Established pharmacological profile for SERMs

Ultima-Nolva by Ultima Pharmaceuticals is an effective tamoxifen citrate option for advanced post-cycle therapy and estrogen receptor research.